Table 3.

Selected demographic and clinical characteristics stratified by geographic region

	North America¹ (n=1960)	Latin America¹ (n=694)	Spain (n=366)

Race/Ethnicity, n (%)^*
Non-Hispanic White	1172 (59.8)	0	366 (100)
Hispanic	226 (11.5)	690 (99.4)	0
Non-Hispanic Black²	488 (24.9)	4 (0.6)	0
Other³	74 (3.8)	0	0

Mean age, years^*	62 ± 11	66 ± 11	65 ± 11

Male, %^*	60	65	75

Lifestyle behaviors prior to qualifying stroke
Smoking status, %^*
Never	36	52	33
Former	42	38	35
Current	22	9	32
Alcohol use (≥ 7 drinks per week), %^*	13	8	22
Exercise, mean times per week^*	3 ± 3	2 ± 3	5 ± 3

Medical history prior to qualifying stroke, %
Hypertension^*	78	76	60
Hyperlipidemia^*	57	33	37
Diabetes	36	38	36
Parental history of stroke^*	32	23	28
Ischemic heart disease^*	14	4	5
Prior symptomatic small subcortical stroke	10	11	8
Prior subcortical TIA	6	4	6
Intermittent claudication/peripheral vascular disease^*	4	1	5
Heart failure	1	0	0

Antithrombotic medication used regularly in 7 days before qualifying stroke, %^*	37	20	21

Rankin score of 0–1, %	67	64	67

Barthel Index ≥ 95, %^*	85	64	84

Mean body mass index^*	30 ± 7.5	27 ± 5	28 ± 4

Mean systolic blood pressure (mmHg)^*	143 ± 19	144 ± 21	139 ± 16
Mean diastolic blood pressure (mmHg)	78 ± 11	79 ± 12	78 ± 9

Anti-hypertensive medications, %^*	87	84	75
Lipid-lowering medications, %^*	77	62	72
Hypoglycemic medications, %	33	34	34

Data are presented as percentages, mean ± SD, or median (interquartile range)

difference among groups significant at p <0.01

North America (United States and Canada); Latin America (Mexico, Ecuador, Peru, Chile, and Argentina)

includes 22 patients (18 in North America and 4 in Latin America) who also reported Hispanic ethnicity

Other includes those who reported their race as American Indian/Alaskan Native, Asian/Pacific Islander, or ‘other’